Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment

By Ito F.   Kawamura N.   Ichimura T.   Tsujimura A.   Ishiko O.   Ogita S.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite

Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences

By Kadowaki M.   Murakami T.   Morita J.   Terada Y.   Yaegashi N.   Okamura K.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 1081-1082

Elsevier

Access to resources Recommend Favorite

Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles - influence on markers of cardiovascular disease

By Palomba S.   Affinito P.   Di Carlo C.   Bifulco G.   Nappi C.  

Fertility and Sterility, Vol. 72, Iss. 5, 1999-11 ,pp. : 889-895

Elsevier

Access to resources Recommend Favorite

Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist

By Efstathiadou Z.   Tsatsoulis A.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite